OppenheimerFunds’s Viridian Therapeutics VRDN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q1	$88K	Buy	2,110 +141	+7%	+$5.88K	﹤0.01%	1740
2018 Q4	$90K	Buy	1,969 +609	+45%	+$27.8K	﹤0.01%	1780
2018 Q3	$114K	Buy	+1,360	New	+$114K	﹤0.01%	1802